14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Sep 10, 2019 $0.0550 $0.0550 $0.0550 $0.0550 4 108
Sep 09, 2019 $0.0455 $0.0550 $0.0455 $0.0550 13 700
Sep 06, 2019 $0.0455 $0.0503 $0.0455 $0.0503 2 841
Sep 05, 2019 $0.0455 $0.0503 $0.0455 $0.0503 398
Sep 04, 2019 $0.0503 $0.0503 $0.0503 $0.0503 21
Sep 03, 2019 $0.0503 $0.0503 $0.0503 $0.0503 1 008
Aug 30, 2019 $0.0470 $0.0580 $0.0455 $0.0580 2 602
Aug 29, 2019 $0.0600 $0.0600 $0.0600 $0.0600 5 034
Aug 28, 2019 $0.0470 $0.0600 $0.0470 $0.0600 319
Aug 27, 2019 $0.0470 $0.0600 $0.0470 $0.0600 638
Aug 26, 2019 $0.0550 $0.0570 $0.0528 $0.0570 1 866
Aug 23, 2019 $0.0630 $0.0630 $0.0630 $0.0630 69
Aug 22, 2019 $0.0630 $0.0630 $0.0630 $0.0630 121
Aug 21, 2019 $0.0455 $0.0630 $0.0455 $0.0630 2 996
Aug 20, 2019 $0.0457 $0.0457 $0.0457 $0.0457 62
Aug 19, 2019 $0.0457 $0.0457 $0.0457 $0.0457 157
Aug 16, 2019 $0.0457 $0.0457 $0.0457 $0.0457 6 835
Aug 15, 2019 $0.0458 $0.0530 $0.0457 $0.0457 13 338
Aug 14, 2019 $0.0456 $0.0456 $0.0456 $0.0456 163
Aug 13, 2019 $0.0456 $0.0625 $0.0456 $0.0456 9 373
Aug 12, 2019 $0.0457 $0.0632 $0.0457 $0.0632 588
Aug 09, 2019 $0.0632 $0.0632 $0.0632 $0.0632 60
Aug 08, 2019 $0.0550 $0.0644 $0.0478 $0.0632 17 703
Aug 07, 2019 $0.0644 $0.0644 $0.0644 $0.0644 12
Aug 06, 2019 $0.0644 $0.0644 $0.0644 $0.0644 469
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT